Janus Henderson Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $166M | Buy |
2,644,539
+645,534
| +32% | +$45M | 0.08% | 213 |
|
|
2025
Q4 | $133M | Sell |
1,999,005
-694,760
| -26% | -$44.9M | 0.06% | 238 |
|
|
2025
Q3 | $181M | Buy |
2,693,765
+145,719
| +6% | +$11.5M | 0.08% | 197 |
|
|
2025
Q2 | $222M | Buy |
2,548,046
+15,038
| +0.6% | +$1.18M | 0.11% | 180 |
|
|
2025
Q1 | $172M | Buy |
2,533,008
+2,011,196
| +385% | +$164M | 0.09% | 197 |
|
|
2024
Q4 | $40.6M | Sell |
521,812
-34,369
| -6% | -$2.54M | 0.02% | 422 |
|
|
2024
Q3 | $37.3M | Buy |
556,181
+31
| +0% | +$2.55K | 0.02% | 446 |
|
|
2024
Q2 | $63.1M | Sell |
556,150
-3,368
| -0.6% | -$426K | 0.03% | 334 |
|
|
2024
Q1 | $77.6M | Sell |
559,518
-14,999
| -3% | -$1.89M | 0.04% | 302 |
|
|
2023
Q4 | $71.3M | Sell |
574,517
-886,978
| -61% | -$90.6M | 0.04% | 309 |
|
|
2023
Q3 | $136M | Buy |
1,461,495
+79,556
| +6% | +$8.97M | 0.09% | 207 |
|
|
2023
Q2 | $178M | Buy |
1,381,939
+608,423
| +79% | +$73.6M | 0.11% | 187 |
|
|
2023
Q1 | $89.9M | Sell |
773,516
-1,889,968
| -71% | -$212M | 0.06% | 269 |
|
|
2022
Q4 | $302M | Sell |
2,663,484
-7,108,558
| -73% | -$780M | 0.22% | 119 |
|
|
2022
Q3 | $787M | Buy |
9,772,042
+3,676,314
| +60% | +$311M | 0.29% | 83 |
|
|
2022
Q2 | $454M | Sell |
6,095,728
-555,384
| -8% | -$50.7M | 0.31% | 82 |
|
|
2022
Q1 | $851M | Sell |
6,651,112
-616,552
| -8% | -$67.4M | 0.41% | 52 |
|
|
2021
Q4 | $976M | Sell |
7,267,664
-3,195,296
| -31% | -$459M | 0.41% | 49 |
|
|
2021
Q3 | $1.43B | Sell |
10,462,960
-1,011,440
| -9% | -$128M | 0.63% | 24 |
|
|
2021
Q2 | $1.22B | Buy |
11,474,400
+3,998,492
| +53% | +$384M | 0.52% | 27 |
|
|
2021
Q1 | $672M | Buy |
7,475,908
+4,995,320
| +201% | +$469M | 0.31% | 80 |
|
|
2020
Q4 | $229M | Buy |
2,480,588
+526,896
| +27% | +$47M | 0.11% | 201 |
|
|
2020
Q3 | $201M | Buy |
1,953,692
+262,112
| +15% | +$27.4M | 0.11% | 197 |
|
|
2020
Q2 | $171M | Sell |
1,691,580
-1,448,388
| -46% | -$130M | 0.1% | 217 |
|
|
2020
Q1 | $211M | Buy |
3,139,968
+796,424
| +34% | +$49.6M | 0.15% | 151 |
|
|
2019
Q4 | $128M | Sell |
2,343,544
-881,720
| -27% | -$41.8M | 0.07% | 296 |
|
|
2019
Q3 | $120M | Sell |
3,225,264
-777,660
| -19% | -$30.2M | 0.07% | 313 |
|
|
2019
Q2 | $150M | Sell |
4,002,924
-1,807,016
| -31% | -$56.8M | 0.08% | 273 |
|
|
2019
Q1 | $173M | Buy |
5,809,940
+821,608
| +16% | +$28.9M | 0.1% | 247 |
|
|
2018
Q4 | $149M | Sell |
4,988,332
-1,856,556
| -27% | -$58.9M | 0.1% | 263 |
|
|
2018
Q3 | $245M | Sell |
6,844,888
-10,924,604
| -61% | -$339M | 0.13% | 198 |
|
|
2018
Q2 | $422M | Sell |
17,769,492
-9,895,672
| -36% | -$210M | 0.24% | 111 |
|
|
2018
Q1 | $513M | Sell |
27,665,164
-6,994,932
| -20% | -$103M | 0.3% | 83 |
|
|
2017
Q4 | $497M | Sell |
34,660,096
-619,204
| -2% | -$8.05M | 0.3% | 82 |
|
|
2017
Q3 | $432M | Buy |
35,279,300
+7,964,376
| +29% | +$141M | 0.28% | 98 |
|
|
2017
Q2 | $500M | Buy |
27,314,924
+27,288,092
| +101,700% | +$504M | 0.34% | 66 |
|
|
2017
Q1 | $568K | Hold |
26,832
| – | – | ﹤0.01% | 762 |
|
|
2016
Q4 | $401K | Buy |
+26,832
| New | +$475K | ﹤0.01% | 792 |
|
Other funds holding DXCM
VCM
VPM
Janus Henderson Group's DXCM Position: Q1 2026 in Review
Janus Henderson Group increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $45M and bringing the position to 2,644,539 shares worth $166M. The position accounts for 0.08% of the portfolio, ranked #213.
Janus Henderson Group first reported a position in DXCM in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.43B in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Janus Henderson Group held 2,644,539 shares of DexCom worth $166M as of Q1 2026.
- Janus Henderson Group bought 645,534 DexCom shares in Q1 2026, an estimated $45M.
- DexCom made up 0.08% of Janus Henderson Group's portfolio in Q1 2026, its #213 holding.
- Janus Henderson Group first reported a position in DexCom in Q4 2016 and has held it in 38 quarters since.
- Janus Henderson Group's DexCom position peaked at $1.43B in Q3 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.